Providers

How Many of Your Patients Need to Lose Weight?

At Reset Wellness, We Believe Weight Loss is Healthcare Your Patients Deserve!

>70 % of Americans are considered overweight! That’s 7 out of every 10 of your patients!

42.5% of Americans are actually considered obese. That’s 4 of every 10 of your patients!

87.2 % of Americans are suffering from some degree of metabolic dysfunction. (Insulin Resistance)

We Make the Weight Loss Conversation is as Easy as 1-2-3

Use the BMI chart we provide you to show your patient where they measure and why it is important they lose weight.

Tell them you have a medically based program you recommend.

Hand them the rack card, have them scan the QR code for an informational video and to contact us!

The Ideal Protein Protocol is the Leading Nutritional Intervention for Obesity and Obesity-Related Disorders!

Supervised Protocol

The Ideal Protein Program is a medically developed and professionally supervised protocol the is designed to restore metabolic health, and in the process, create meaningful weight loss and long-lasting lifestyle change to Reset What is Possible for Your Patient’s Life! It targets the very cause of Metabolic Syndrome - Hyper-Insulinemia and Insulin Resistance. It is designed to restore a healthy balanced ratio of Insulin and Glucagon through therapeutic carbohydrate restriction.

Proven Weight Loss and Improved Metabolic Health

View our collection of clinical trials, case studies and peer-reviewed research.

https://onlinelibrary.wiley.com/doi/10.1002/osp4.567

This study concludes that “this 3-month randomized, parallel group trial showed that the IP system resulted in greater weight loss and reduction in several CVD risk factors than a guideline-based LCLF dietary behavioral intervention among black and white adults with obesity and additional CVD risk factors. Thus, the IP system appears to be a safe and efficacious way to lose weight and reduce CVD risk factors among men and women with obesity and additional CVD risk factors. Further research is warranted to examine outcomes over the longer term.”

https://www.nature.com/articles/s41467-021-25667-4

The primary objective of the study, published in Nature Communications, was to determine if a Pharm-TCR diet can safely reduce and/or eliminate the use of glucose-lowering medications and lead to improvements in A1C, body composition, cardiometabolic health, and quality of life.² Of the 188 patients that participated in the 12-week study, 98 patients followed a Pharm-TCR diet, and 90 patients received treatment-as-usual.

After 12 weeks, 35.7% of patients experienced a discontinuation of glucose lowering medications, 1.4% reduction in A1C, 2.0mmol/L reduction in serum glucose, 34.3% reduction in triglycerides, 12 kg/26.45 lbs. reduction in body weight, 11.4 cm/ 4.48 in. reduction in waist circumference, 4.4 kg/m2 in BMI, and 3.7% reduction in body fat percentage.

As stated in the 2019 Diabetes Care report, “low-carbohydrate eating patterns, especially very low-carbohydrate (VLC) eating patterns, have been shown to reduce A1C and the need for antihyperglycemic medications.”

https://www.nature.com/articles/s41467-021-25667-4https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227162/

The goal of this study was to examine the impact of the Ideal Protein Protocol on metabolic parameters and markers of liver disease in patients with non-alcoholic steatohepatitis.

 

The findings highlight the beneficial effects of the Ideal Protein Protocol on liver enzymes and a marker of liver fibrosis among a group of patients with NASH⁸’⁹

Experts estimate that the prevalence of NASH is up to 12%, over 16 million US adults, with estimates of a 63% increase by year 2030.

https://www.researchgate.net/publication/259309369_Low_Carbohydrate_Dietary_Intervention_Improves_Insulin_Hormonal_Levels_and_Inflammatory_Markers_in_Early_Stage_Postmenopausal_Breast_Cancer_Survivors

A 19-week study with the Avera Cancer Institute reported a 40% reduction in C-reactive protein for patients who completed the Ideal Protein Protocol. The study also reported a rapid decline in resting fasting insulin and a mean weight loss of 19.9% body fat.

Studies show increased CRP levels are associated with a higher risk for inflammatory conditions.

https://www.businesswire.com/news/home/20161103005184/en/Award-Winning-Research-Linking-Ideal-Protein-Protocol#:~:text=Effect%20of%20a%20Ketogenic%20Diet%20on%20Advanced%20Lipid%20Profiles%20(Graphic:

study conducted by Aspirus, reported that after 3 years, participants who completed the Ideal Protein Protocol maintained an average weight loss of 12.8%, resulting in an 18% reduction in overall average claim care costs, saving an average of $916.97 per participant, per year.

A study published by The American Journal of Clinical Nutrition reports that if individuals can succeed at maintaining their weight loss for 2 or more years, they can reduce their risk of subsequent regain by nearly 50%.

https://www.medaxiom.com/clientuploads/CorporatePartners/docs/ASPIRUS_metabolic_parameters.pdf

According to a study conducted and published by Aspirus, an eight-hospital health system in Wisconsin and Michigan, entitled Effect of the Ideal Protein Weight Loss Method on Weight Loss and Metabolic Parameters,¹ 233 patients completed at least 12 weeks of the Protocol. The 12-week results were presented at the Cleveland Clinic’s 9th Annual Obesity Summit and at the Annual Scientific Meeting of the National Obesity Society.

Our peer-reviewed, published research demonstrates that, among patients who completed the study, metabolic health can be improved in as little as 12 weeks.